title: In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda.
abstract: In an in vivo study of antimalarial sensitivity in Kabarole District, Western Uganda, 82% of asymptomatic malarial infections and 86% of symptomatic infections were chloroquine sensitive. Of persons with symptomatic malaria, 88% were sensitive to sulfadoxine-pyrimethamine (Fansidar). Amodiaquine cleared parasites in all persons in whom it was used. Over the course of the past five years, there appears to be no substantial increase in the extent of chloroquine resistance in Western Uganda.
authors.affiliation: Ministry of Health, Entebbe, Uganda.
authors.forename: J
authors.initials: J
authors.lastname: Kamugisha
authors.forename: W
authors.initials: W
authors.lastname: Kipp
authors.forename: G
authors.initials: G
authors.lastname: Burnham
mesh_terms: D000328:Adult; D000655:Amodiaquine / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology* / Q000627:therapeutic use; D002648:Child; D002738:Chloroquine / Q000494:pharmacology; D004338:Drug Combinations; D004351:Drug Resistance; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000469:parasitology; D008826:Microbial Sensitivity Tests; D010963:Plasmodium falciparum / Q000187:drug effects*; D011739:Pyrimethamine / Q000494:pharmacology; D013413:Sulfadoxine / Q000494:pharmacology; D014454:Uganda
chemical_list: D000962:Antimalarials; D004338:Drug Combinations; D000655:Amodiaquine; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D011739:Pyrimethamine